EyePoint, Inc. (EYPT) Corporate Subsidiaries
EyePoint, Inc. (EYPT) is a publicly traded company on the Nasdaq, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EYPT
CIK: 1314102
Exchange: Nasdaq
SIC 3826: Laboratory Analytical Instruments
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 6/30/2017 12:00:00 AM
Lead Engagement PartnerSara Albano
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001623632-26-001550 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | 8-K | 0001193125-26-387197 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-08 | — | SCHEDULE 13G Filing | 0001274173-26-000222 | View SEC Doc Filr Page |
| 4 | 2026-08-24 | 2026-08-20 | PRIMARY DOCUMENT | 0001429932-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-18 | PRIMARY DOCUMENT | 0001530968-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | 8-K | 0001193125-26-353308 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003689 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0000919574-26-004955 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | S-8 | 0001193125-26-335176 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335037 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-333821 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-31 | — | SCHEDULE 13G Filing | 0002100119-26-001390 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001193125-26-324866 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002491 | View SEC Doc Filr Page |
| 144/A | 2026-07-22 | — | 144/A Filing | 0001959173-26-005330 | View SEC Doc Filr Page |
| 144/A | 2026-07-22 | — | 144/A Filing | 0001959173-26-005318 | View SEC Doc Filr Page |
| 144 | 2026-07-21 | — | 144 Filing | 0001959173-26-005309 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-13 | 8-K | 0001193125-26-307792 | View SEC Doc Filr Page |
| 4 | 2026-07-14 | 2026-07-10 | PRIMARY DOCUMENT | 0001630864-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | PRIMARY DOCUMENT | 0002013623-26-000012 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001193125-26-276688 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-03 | — | SCHEDULE 13G Filing | 0001831942-26-000028 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-25 | PRIMARY DOCUMENT | 0001429932-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062616 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-222750 | View SEC Doc Filr Page |